Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Immunovant Inc’s stock clocked out at $15.43, up 5.11% from its previous closing price of $14.68. In other words, the price has increased by $5.11 from its previous closing price. On the day, 1.13 million shares were traded.
Ratios:
To gain a deeper understanding of IMVT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.04 and its Current Ratio is at 6.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 03, 2025, initiated with a Hold rating and assigned the stock a target price of $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 09 ’25 when Salzmann Peter sold 28,094 shares for $12.99 per share. The transaction valued at 364,941 led to the insider holds 1,186,512 shares of the business.
Fromkin Andrew J. sold 8,000 shares of IMVT for $156,769 on Mar 07 ’25. The Director now owns 91,913 shares after completing the transaction at $19.60 per share. On Mar 07 ’25, another insider, ANDREW J FROMKIN, who serves as the Director of the company, bought 8,000 shares for $19.52 each.
Stock Price History:
Over the past 52 weeks, IMVT has reached a high of $34.47, while it has fallen to a 52-week low of $12.72. The 50-Day Moving Average of the stock is -17.69%, while the 200-Day Moving Average is calculated to be -40.19%.
Shares Statistics:
A total of 147.20M shares are outstanding, with a floating share count of 68.25M. Insiders hold about 59.82% of the company’s shares, while institutions hold 49.43% stake in the company.
